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Impaired UPSNeurodegenerative diseases are attributed to impairment of the ubiquitin–proteasome system
(UPS). Oxidative stress has been considered a contributing factor in the pathology of impaired
UPS by promoting protein misfolding and subsequent protein aggregate formation. Increasing evi-
dence suggests that NADPH oxidase is a likely source of excessive oxidative stress in neurodegener-
ative disorders. However, the mechanism of activation and its role in impaired UPS is not
understood. We show that activation of NADPH oxidase in a neuroblastoma cell line (SHSY-5Y)
resulted in increased oxidative and nitrosative stress, elevated cytosolic calcium, ER-stress, impaired
UPS, and apoptosis. Rac1 inhibition mitigated the oxidative/nitrosative stress, prevented calcium-
dependent ER-stress, and partially rescued UPS function. These ﬁndings demonstrate that Rac1
and NADPH oxidase play an important role in rotenone neurotoxicity.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The ubiquitin–proteasome system (UPS) is a dynamic cellular
pathway involved in the deaggregation of misfolded proteins
through proteasome degradation [1]. Defective UPS function is
frequently observed in patients afﬂicted with neurodegenerative
diseases, such as Alzheimer disease, Parkinson disease, and
Huntington disease [1]. Increased oxidative stress has long been
implicated in the pathogenesis of impaired UPS function by
promoting protein misfolding and subsequent protein aggregate
formation [1]. However, the source of ROS and the mechanisms
by which ROS is elevated have not been elucidated. Maintaining
the integrity of UPS function will likely prove beneﬁcial in these
neurodegenerative diseases; and therefore, understanding the
mechanisms by which oxidative stress impairs UPS is very crucial
to the development of treatments.
Nicotinamide adenine dinucleotide phosphate-oxidase (NADPH
oxidase, Nox) is a plasma membrane-bound superoxide producing
enzyme complex that is essential to maintaining functionality of
the host defense mechanism [2]. There is an increasing body of
work suggesting that activation of Nox leads to the pathogenesis
of progressive neurodegeneration and chronic inﬂammation [2–
4]. Activation of Nox leads to excess oxidative stress, resulting inaggregate formation and neuronal cell death [5–7]. Exposure to
rotenone, a widely used pesticide, increases the risk to develop
neurodegenerative disorders [1,8,9]. Rotenone is known to inhibit
complex 1 of the mitochondrial respiratory chain and has been
widely used in human neuroblastoma cells (SHSY-5Y) as an in-vitro
experimental model of Parkinson’s disease [1]. More recently, rote-
none has been implicated as a potential regulator of Nox activity,
augmenting oxidative stress in neuronal cells and leading to neuro-
degeneration [3,10].
The Nox complex consists of membrane-bound subunits
gp91phox and p22phox, and cytosolic subunits p47phox, p67phox,
and p40phox [11]. Assembly of these multiple subunits into a mem-
brane complex is required for enzyme activity [12]. Upon stimula-
tion, p47phox is phosphorylated and translocates from the cytosol
to the plasma membrane where it binds with the gp91phox/p22phox
complex [13]. Rotenone directly binds with the catalytic subunit
gp91phox; and this interaction enhances p67phox translocation from
the cytosol to the membrane complex [3]. Earlier studies have
demonstrated that the Rho-like GTPase, Rac1, is necessary for
structural and functional activation of the Nox complex by amelio-
rating the gp91phox–p67phox interaction [3]. The inactive form of
Rac1 remains in the cytosol as a Rac1–GDP complex [14]. Upon dis-
sociation from its cytosolic complex, Rac1 translocates to the
membrane with guanosine diphosphate (GDP) and guanine nucle-
otide dissociation inhibitor (GDI) [14]. The conversion of the inac-
tive GDP-bound Rac1 to active GTP-bound Rac1, with GDP/GTP
conversion, is regulated by the guanine nucleotide exchange
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[3]. Active-Rac1 induces activation of the Nox complex by enhanc-
ing or promoting the interaction between gp91phox and p67phox [3].
Activation of Nox transfers electrons from intracellular NADPH
across the plasma membrane to extracellular molecular oxygen,
generating extracellular superoxide and its downstream reactive
oxygen species (ROS) [15].
Excess superoxide production has also been implicated in the
activation of plasma membrane calcium channels, resulting in in-
creased intracellular calcium levels [16]. Intracellular calcium lev-
els may also be enhanced by pathophysiologic calcium release
from intracellular stores, the endoplasmic reticulum (ER) [16]. Ele-
vated cytosolic calcium activates neuronal NO-synthase (nNOS),
increasing reactive nitrogen species (RNS, ⁄NO) production [17].
Together, reactive oxygen and nitrogen species alter cellular
homeostasis and eventually elicit impaired UPS function.
As there is mounting evidence that increased oxidative stress is
associated with impaired UPS function and neurodegeneration,
understanding the mechanism(s) by which Nox-induced oxidative
stress leads to impaired UPS function is critical as we seek thera-
peutic strategies for these neurodegenerative disorders. In this
study, we found that rotenone increased Nox-induced oxidative
stress and protein aggregate formation via impaired UPS in
SHSY-5Y cells. Inhibition of Rac1 mitigated Nox-dependent oxida-
tive stress, diminished protein aggregate formation, and partially
rescued UPS function. Collectively, these ﬁndings demonstrate that
Rac1 plays an important role in oxidative stress-induced impaired
UPS function in SHSY-5Y cells. Targeting either Rac1 or Nox may
prove to be therapeutically beneﬁcial for treating neurodegenera-
tive disorders.
2. Materials and methods
2.1. Redox sensitive constructs
The Nox-speciﬁc redox sensor p47-roGFP and the glutathione
redox potential-speciﬁc sensor Grx1-roGFP2 were designed as pre-
viously described by our lab [18]. To generate an ER targeted-
redox-sensitive-GFP (ER-roGFP), the calreticulin signal sequence
MLLPVLLLGLLGAAAD was added 50 and an ER retention sequence,
KDEL, was added 30 to the modiﬁed roGFP1 (roGFP1-iL, kind gift
from Dr. James Remington [19]) using the forward primer (roER-
NotI)50AAGCTTGCGGCCGCCACATGCTGCTGCCCGTCCCCCTGCTGCT
GGGCCTGCTGGGCGCCGCCGCCGACAGTAAAGGAGAAGAACTTTTC 30
and reverse primer (roERXbaI)50ACTCGATCTAGATTACAGCTCGTCC
TTTTTGTATAGTTCATCCATGCC 30, and fused to the pCDNA3 vector
2.2. Reagents and antibodies
Rotenone (RT), antimycin-A, pegulated-catalase (PEG-cat) and
catalase (Cat) were purchased from Sigma–Aldrich. Rac1 inhibitor
(Rac1(-), C24H35N73HCl) was from TOCRIS bioscience. Fura-2/AM,
Fluo-4/AM, DAF-FM, Amplex-red, mitoSOX and DCFH-DA (6-car-
boxy-20,70-dichlorodihydroﬂuorescein diacetate) were from Invit-
rogen. Phosphate buffered saline (PBS) was from GIBCO. The
Nox-speciﬁc peptide inhibitor gp91 ds was from Biosynthesis,
Lewisville, TX. Anti-Ubiquitin was from Dako, anti-poly (ADP-ri-
bose) polymerase (PARP) was from Cell Signaling Technology,
anti-GAPDH (glyceraldehyde-3-phosphate dehydrogenase) was
from Millipore, and anti-PDI (protein disulﬁde isomerase) was
from Abcam.
2.3. Cell culture and treatment
SHSY-5Y cell line is used as amodel of in vitro neurodegenerative
disease studies because this cell line has biochemical properties ofhuman neurons in vivo. Moreover, since these cells are tumor de-
rived, they can continuously grow and divide [20]. The cells were
differentiated to provide mature neuron-like phenotype [21].
SHSY-5Y cells (ATCC CRL2266™) were grown in DMEM-F12 (1:1,
Gibco) supplemented with 10% heat inactivated fetal bovine serum
(FBS, Atlanta Biologicals), 2 mM L-glutamine, 100 U/ml penicillin
and 100 mg/ml streptomycin (Gibco). Cells were seeded on 96-well
plates (Costar) at a density of 12000 cells/well. Cells were treated
with rotenone (500 nM, 24 h), Rac1 inhibitor (50 lM, 1 h), gp91
ds (5 lM, 1 h), and catalase (5 lM, 1 h) as indicated.
2.4. Live cell imaging
Cells were seeded (2000/well) on 96-well plates for either intra-
cellular (DCFH-DA) or extracellular (Amplex-red H2O2 assay) ROS
measurements as suggested by the manufacturer’s protocol. For
assessment of changes in the glutathione redox potential or ER re-
dox potential cells were transiently transfected with either Grx1-
roGFP2 or ER-roGFP respectively. For assessment of Nox activity
cells were transfected with our Nox speciﬁc redox biosensor p47-
roGFP [18]. Transfection was done using X-tremeGENE HP DNA
Transfection Reagent (Roche) at a ratio of 3:1 (Reagent to DNA).
Changes in the redox sensors were assessed as we have previously
described [18].
2.5. Assessment of calcium inﬂux by Mn2+ quench
Cells were seeded (2000 cells/well) in 96-well plates for cal-
cium inﬂux measurements. Calcium inﬂux was assessed by a
well-established Mn2+ quench of Fura-2 ﬂuorescence [22]. Due
to the negligible concentration of intracellular Mn2+ and that
Mn2+ permeates through calcium channels, the rate of quench
of Fura-2 ﬂuorescence was assessed in the presence of extracel-
lular MnCl2 as a measure of plasma membrane calcium perme-
ability. Rotenone treated or untreated cells were washed with
Ringer solution containing in mM: 146 NaCl, 4.7 KCl, 1.8 CaCl2,
0.6 MgSO4, 1.6 NaHCO3, 0.13 NaH2PO4, 7.8 Glucose and 20
HEPES. Cells were loaded with 5 lM Fura-2 and incubated for
30 min, at room temperature. Cells were then washed with Ring-
er solution and incubated for 20 min at room temperature to
allow for dye de-esteriﬁcation. Fluorescence signals were moni-
tored at the calcium-isosbestic (360 nm) and the calcium-free
excitation (380 nm) wavelengths in either normal Ringer
(0–120 s) or Ringer in which CaCl2 was replaced by MnCl2
(1.8 mM), The rate of Mn2+ quench of the 360 nm signal was
calculated over the last 60 s.
2.6. Intracellular calcium measurements and RNS measurement
Cells were seeded (12000 /well) in a 96-well plate in DMEM for
intracellular calcium measurements. Cells were washed with PBS
followed by incubation with the ﬂuorescent calcium indicator
Fluo- 4/AM (5 lM) for 30 min at room temperature. Cells were
washed with PBS and the dye allowed to de-esterify for 20 min
at room temperature prior to microscopy. Fluorescent images were
captured with a Zeiss LSM 5 Live inverted confocal microscope
equipped with a 40, 1.2 NA water immersion objective. Excitation
was at 488 nm and emission was captured with a linear detector
after passing through a 495–555 nm band pass ﬁlter. Intensity val-
ues were calculated in ImageJ by outlining cells and calculating
average basal Fluo-4 ﬂuorescence. The single cell data was back-
ground subtracted and the ﬂuorescence of all cells (25 cells) from
a single frame were averaged. RNS was measured using DAF-FM
dye. Excitation was at 488 nm and emission was captured with a
linear detector after passing through a 495–555 nm band pass
ﬁlter.
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We investigated mitochondrial ROS in SHSY-5Y cells using mit-
oSOX. Cells treated with rotenone or antimycin-A (mitochondrial
complex-III chain inhibitor) for 24 h. For measurements of ROS de-
rived from the mitochondria, SHSY-5Y cells were loaded with 5 lmFig. 1. Rac1-inhibition decreases oxidative stress in SHSY-5Y cells. Rotenone increases ov
Nox activity (gp91 ds) or Rac1 (Rac1(-)) rotenone enhances Nox-speciﬁc ROS production,
and catalase (D). Rotenone induces oxidation of cellular glutathione, which is prevente
replicates. ⁄P < 0.05 and ⁄⁄P < 0.01.mitoSOX for 10 min at 37 C. Cells were excited at 488 nm and the
emitted ﬂuorescence was recoded at 560–615 nm.
2.8. Immunoblotting
Cells were seeded onto 60-mm Petri dishes and incubated over-
night to promote adherence. Cells were treated with rotenoneerall intracellular (A) and extracellular (B) ROS, which is attenuated by inhibition of
which is prevented by inhibition of Nox activity with gp91 ds or a Rac1 inhibitor (C),
d by inhibition of either Nox activity or Rac1 (E). Data are representative of three
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Cells were harvested and lysed in RIPA buffer (50 mM Tris–HCl,
ph 7.4, 1% NP40, 0.5% Na-deoxycholate, 0.1% SDS, 150 mM NaCl,
2 mM EDTA, and 50 mM NaF) including a cocktail of protease
(Roche) and phosphatase (SIGMA) inhibitors. Immunoblotting
was carried out with soluble and insoluble protein mixture as pre-
viously described [23]. Densitometric analysis was done using Im-
ageJ software.
2.9. Data analysis
Data are reported as mean ± S.E.M., unless otherwise speciﬁed.
Statistical differences between groups were determined using
ANOVA with Tukey’s post-hoc test. Statistical analysis was
performed in Origin Pro (OriginLab Corporation, Northhampton,
MA) with a signiﬁcance level of ⁄P < 0.05 and ⁄⁄P < 0.01.
3. Results
3.1. Inhibition of Rac1 decreases rotenone-induced ROS production
To investigate whether rotenone induces ROS production via
the Rac1–Nox axis, we measured intra- and extra-cellular ROS
using SHSY-5Y cells upon rotenone administration as a model sys-
tem. General intracellular ROS was measured by assessment of
changes in DCF ﬂuorescence (Fig. 1A). SHSY-5Y cells treated withFig. 2. Rac1-inhibition mitigates Nox-meadiated calcium inﬂux and elevated intracellu
calcium inﬂux (A, B) and subsequent increases in intracellular calcium (C) in SHSY-5Y cel
Dashed line in B indicates normalized value of calcium inﬂux prior addition of extracellrotenone showed a 2 fold increase in DCF ﬂuorescence compared
to untreated cells. Preincubation with the Rac1 inhibitor or the
Nox-speciﬁc inhibitor gp91 ds signiﬁcantly inhibited the rotenone
induced ROS production (Fig. 1A), which were not signiﬁcantly dif-
ferent from controls. The Rac1 inhibitor alone had no effect on
intracellular ROS production, indicating minimal Nox formation
under basal conditions. Production of extracellular ROS was as-
sessed using the peroxidase-based assay for H2O2 by monitoring
the oxidation of membrane impermeable Amplex-red. Rotenone
increased the oxidation of Amplex-red 1.5 fold compared to un-
treated cells (Fig. 1B). Cells preincubated with Rac1 inhibitor and
gp91 ds showed marked decreases in oxidation of Amplex-red
(Fig. 1B), which were not signiﬁcantly different from controls.
Addition of extracellular catalase prevented the oxidation of
Amplex-red upon rotenone exposure (data not shown), suggesting
that the Nox complex produces ROS into the extracellular space,
which diffuses across the plasma membrane to promote intracellu-
lar oxidative stress. Our results indicate that Nox is a major source
of ROS production and that Rac1 plays an important role in activat-
ing this enzyme complex in response to rotenone.
3.2. Role of Rac1 in rotenone-induced Nox-speciﬁc ROS production and
alterations in the glutathione redox potential
Nox-speciﬁc ROS has recently gained attention as a major
source of ROS in the pathology of several neuronal dysfunctionslar calcium in SHSY-5Y cells. Rotenone induces Nox-dependent plasma membrane
ls, which is prevented by inhibition of Nox activity with gp91 ds or a Rac1 inhibitor.
ular Mn2+. Data are representative of four replicates. ⁄P < 0.05 and ⁄⁄P < 0.01.
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roGFP redox biosensor in which redox sensitive GFP is linked to
p47phox [18]. Previous reports have shown that 500 nM rotenone
is able to induce a signiﬁcant amount of apoptosis, by inducing
activation of morphological markers of apoptosis, after 24 h of
treatment [24]. We assessed the dose and time-dependent effect
of rotenone on Nox-speciﬁc ROS generation (Supplementary
Fig. 1). Rotenone at 300 and 500 nM signiﬁcantly increased the oxi-
dation of p47-roGFP after 24 h. No signiﬁcant difference was ob-
served between 24 and 48 h rotenone treatment. Using higher
concentrations of rotenone (>500 nM) induced high levels of cyto-
toxicity (>40%), data not shown. Therefore, we chose 500 nM rote-
none for 24 h in our studies to mimic an acute model of
neurodegeneration.
Rotenone treated cells showed a 2.5 fold higher Nox-speciﬁc
ROS generation than untreated cells (Fig. 1C), suggesting that rote-
none activates Nox. Cells preincubated with the Nox-speciﬁc inhib-
itor, gp91 ds, prior to rotenone treatment showed marked decrease
in ROS generation (Fig. 1C) back to controls levels. Inhibition of
Rac1 signiﬁcantly mitigated p47-roGFP oxidation (Fig. 1C),
suggesting that Rac1 plays an important role in Nox complex for-
mation and activation. Application of extracellular catalase or
PEG-catalase completely abolished the rotentone induced oxida-
tion of p47-roGFP (Fig. 1D), providing further evidence that Nox
produces superoxide into the extracellular space, which likely dis-
mutes into H2O2, and H2O2 penetrates into the intracellular spaceFig. 3. Rac1-inhibition attenuates reactive nitrogen species (RNS) production in SHSY-5
inhibition of Nox activity with gp91 ds or a Rac1 inhibitor (A). Rotenone stimulated mito
of mitochondrial ROS by antimysin-A does not induce calcium inﬂux in SHSY-5y cells (C
extracellular Mn2+. Data are representative of three replicates. ⁄P < 0.05 and ⁄⁄P < 0.01.to promote oxidative stress. As cellular oxidative stress leads to
alterations in the glutathione redox potential we used Grx1-roG-
FP2, a translational fusion between glutaredoxin-1 (Grx1) and roG-
FP2, to monitor the glutathione redox potential [25,26]. Rotenone
treatment shifted the glutathione redox potential of SHSY-5Y cells
to a more oxidized state (3.5–4 fold) compared to untreated cells
(Fig. 1E). Inhibition of either Nox or Rac1 decreased the rote-
none-induced oxidation of glutathione back to control levels
(Fig. 1E).
3.3. Inhibition of Rac1 decreases Nox-mediated calcium inﬂux and
alterations of intracellular calcium
To investigate the relationship between altered Nox function
and calcium homeostasis in our model system we monitored intra-
cellular calcium inﬂux under different conditions. Plasma mem-
brane calcium inﬂux was measured by analyzing the quench of
Fura-2 ﬂuorescence upon addition of extracellular Mn2+ (Fig. 2)
[27]. Rotenone treatment enhanced membrane calcium permeabil-
ity, which was prevented by preincubation with the Nox-speciﬁc
inhibitor gp91 ds (Fig. 2A and B). In addition, rotenone-induced cal-
cium inﬂux was signiﬁcantly reduced upon Rac1 inhibition (Fig. 2A
and B). We also assessed changes in intracellular calcium using
Fluo-4 AM [28–30]. Rotenone increased Fluo-4 ﬂuorescence, which
was prevented by inhibition of either Nox or Rac1 (Fig. 2C). Taken
together, our data strongly support a role for Rac1-dependentY cells. Rotenone increases RNS production in SHSY-5Y cells, which is mitigated by
chondrial ROS production, which is not inhibited by a Rac1 inhibitor (B). Production
, D) Dashed line in D indicates normalized value of calcium inﬂux prior addition of
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homeostasis.
3.4. Inhibition of Rac1 attenuates reactive nitrogen species production
Earlier studies have established a link between increased intra-
cellular calcium and excess RNS production, which can lead to oxi-
dative stress [1,5]. Therefore, we wanted to know whether the
Rac1/Nox-dependent increase in intracellular calcium could lead
to RNS production. We measured ⁄NO with DAF-FM. Rotenone
treatment increased DAF ﬂuorescence, and therefore ⁄NO produc-
tion, which was markedly attenuated by inhibition of Nox activity
or Rac1 (Fig. 3A).
3.5. Mitochondrial-ROS does not alter plasma membrane-calcium
inﬂux in SHSY-5Y cells
Rotenone is a well-knownmitochondrial complex I chain inhib-
itor. While our data strongly support a role for rotenone in activat-
ing Nox, we cannot rule out a contribution of rotenone-induced
oxidative stress via the mitochondria. Rotenone (500 nM) or anti-
mycin-A (5 lM) increased mitochondrial-ROS 1.8 and 4.0 fold,
respectively (Fig. 3B, Supplementary Fig. 2). Cells preincubated
with Rac1 inhibitor did not show any signiﬁcant alteration in mito-
chondrial-ROS generation compared to RT treated cells (Fig. 3B).
Since ROS is involved in activation of plasma membrane calcium
inﬂux and increased calcium is associated with RNS production,Fig. 4. Rac1 plays a major role in Nox-induced ER stress in SHSY-5Y cells. Rotenone induc
or by immunoblotting with anti-PDI antibody (B, C). Inhibition of Nox activity or Rac1 pre
and ⁄⁄P < 0.01.we investigated whether mitochondrial-ROS could increase sarco-
lemmal calcium inﬂux (Fig. 3C and D). Cells treated with antimy-
cin-A, which resulted in the greatest change in MitoSOX, did not
show any signiﬁcant difference in calcium inﬂux compared to un-
treated cells, suggesting that ROS derived speciﬁcally from Nox in-
creased sarcolemmal calcium inﬂux and subsequently RNS
production.
3.6. Inhibition of Rac1 rescues cells from rotenone-mediated ER stress
ROS and RNS together exacerbate oxidative stress, which stim-
ulates ER-stress. Increased intracellular calcium can activate ER
calcium release, leading to ER calcium depletion and ER stress
[27]. To investigate whether rotenone induces ER stress via the
Rac1–Nox axis, we measured oxidative stress within the ER by
assessing redox changes with an ER targeted redox biosensor
(ER-roGFP) in our model system (Fig. 4A). Cells transfected with
ER-roGFP showed a signiﬁcant increase in oxidation upon rotenone
treatment, which was prevented by preincubation with either
gp91 ds or Rac1 inhibitor (Fig. 4A). Earlier studies have established
that ER stress initiates an unfolded protein response (UPR); which
is characterized by a rapid increase in the expression of PDI, an UPR
sensors and marker of ER stress [31,32]. Therefore, we investigated
the effect of rotenone on PDI expression (Fig. 4B and C). Cells trea-
ted with rotenone showed a marked increase in PDI expression
compared to untreated cells, which was signiﬁcantly mitigated
by preincubation with either gp91 ds or Rac1 inhibitor. Thesees ER stress as assessed by the oxidation of the ER targeted redox probe ER-roGFP (A)
vents ER stress. Data are representative of three independent experiments. ⁄P < 0.05
Fig. 5. Rac1 plays a major role in Nox-induced misfolded protein aggregation and apoptotic cell death in SHSY-5Y cells. Rotenone induces misfolded protein aggregation in
the insoluble (A, C) and soluble (B, C) protein fractions as measured by accumulation of ubiquitinated proteins. Rotenone also increases cleaved PARP-1, indicating increased
apoptosis (D, E). Both misfolded protein aggregation and apoptosis was prevented by inhibition of Rac1. Data are representative of three independent experiments. ⁄P < 0.05
and ⁄⁄P < 0.01.
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Rac1 plays an important role in rotenone-induced oxidative stress
in the ER of SHSY-5Y cells.
3.7. Inhibition of Rac1 prevents rotenone-induced protein aggregation
and apoptotic cell death
Oxidative/nitrosative stress can lead to misfolded protein
aggregation [33]. Therefore, we were interested whether rotenone
induced Nox mediated oxidative stress could lead to impaired UPS.
Using an anti-ubiquitin antibody we found that rotenone treated
cells showed accumulation of ubiquitinated protein in both the
soluble and insoluble protein fractions (Fig. 5A–C). However, cells
preincubated with Rac1 inhibitor prior to rotenone treatment
showed a marked decrease in accumulation of high molecularweight bands in both fractions (Fig. 5A–C). We found that rotenone
also induced apoptosis as evidenced by an increase in cleaved
PARP, which was attenuated upon inhibition of Rac1 (Fig. 5D and
E). Cells treated with Rac1 inhibitor itself showed no signiﬁcant in-
crease in protein aggregation or cleaved PARP-1. Taken together,
our results indicate that Nox-speciﬁc oxidative stress plays a major
role in impaired UPS in SHSY-5Y cells and that Rac1 plays an
important role in maintaining the homeostasis of the UPS (see
Fig. 6).
4. Discussion
Oxidative stress and impaired UPS are the two most common
features frequently observed in neurodegenerative diseases [1].
Activation of Nox complex is attributed as a major source of
Fig. 6. Proposed mechanism for the role of the small GTPase Rac1 in Nox-mediated oxidative stress and neuronal cell death via impaired UPS function. The environmental
pesticide rotenone induces Rac1-dependent activation of Nox complex, which increases oxidative stress via excess ROS and RNS production. Increased oxidative stress
mediates misfolded protein aggregation, ER stress, impaired UPS and subsequent cell death.
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Previously Zhou et al. demonstrated that rotenone activates Nox by
promoting a stronger interaction between the membrane subunit
gp91phox and the cytosolic subunit p67phox [3]. However, the mech-
anism of action of Nox-derived ROS in the pathology of impaired
UPS is still unclear. Therefore, understanding the interface between
the onset of Nox-mediated ROS generation and impaired UPS is
important for therapeutic aspects of neurodegenerative diseases.
In this study we have shown that rotenone-induced activation of
Nox increases calcium inﬂux, enhances calcium-dependent ER-
stress and ultimately leads to impaired UPS and apoptotic cell
death. Furthermore, we have also demonstrated that inhibition of
Rac1, a key regulatory factor in the formation of the Nox complex,
mitigates Nox-mediated increases in intracellular calcium, pre-
vents calcium-dependent ER-stress and rescues the homeostasis
of UPS function.
Consistent with a previous report [3], we found that rotenone
leads to activation of Nox and ROS generation. Inhibition of Rac1
prevents the excess ROS generation by Nox and stabilizes the
homeostasis of cellular glutathione redox balance, which is imper-ative for proper protein folding. Our data suggest that Rac1 is a key
regulator of Nox-dependent ROS production and that targeting
either Rac1 or Nox may prove beneﬁcial in neurodegenerative
diseases.
Previous studies have suggested that Nox-speciﬁc superoxide
production enhances plasma membrane calcium permeability
[34,35]. We found that activation of Nox increased calcium inﬂux
and intracellular calcium levels, both of which were signiﬁcantly
blunted upon Rac1 inhibition. Alterations in intracellular calcium
homeostasis can lead to excessive RNS generation via nNOS-activa-
tion (for review see [17]). Our data suggest that rotenone-induced
activation of Nox leads to increased ⁄NO production, which was
markedly attenuated upon inhibition of Rac1. While the mecha-
nisms by which Nox induces increased calcium inﬂux and RNS
are still under investigation, our ﬁndings indicate that Rac1 is a
key regulatory factor in excessive RNS production.
The DCFH assay and DAF-FM have been widely used to monitor
ROS and RNS production, respectively. DCF is non-speciﬁc and can
be oxidized by a number of reactive oxygen and nitrogen species
and is also susceptible to light induced oxidation [36]. While DAF
480 R. Pal et al. / FEBS Letters 588 (2014) 472–481is more speciﬁc to RNS, it can be oxidized by peroxidases in the
presence of H2O2 [37]. To overcome some of these limitations we
have used genetically encoded redox sensitive green ﬂuorescent
protein [38]to monitor subcellular redox potential from NADPH
oxidase using p47-roGFP [18], within the ER using our newly con-
structed ER-roGFP, or the GSH/GSSG redox pair using Grx1-roGFP2
[25]. While we are making great strides in the development of ge-
netic probes to measure ROS, there is still a need for more selective
indicators with subcellular speciﬁcity for RNS.
Excessive ROS production is a major mediator of ER-stress
among numerous pathological conditions [39]. ER-stress response
is afﬂicted with an adaptive signaling cascade known as the un-
folded protein response (UPR) [39]. Excess ROS generation medi-
ates unfolded or misfolded protein aggregation, which stimulates
the prolonged UPR [39]. ER-stress-mediated prolonged UPR leads
to general translational attenuation and hindrance in ER-associ-
ated degradation of unfolded or misfolded proteins [39,40]. This
phenomenon promotes accumulation of high molecular ubiquiti-
nated proteins and impaired UPS [40]. PDI is a chaperone protein
that remains in the ER-lumen and assists in the maturation and
transportation of unfolded protein via thiol disulﬁde exchange.
Previous work has shown that rotenone can lead to S-nitrosyla-
tion of PDI (catalytically inactive form), initiating misfolded
protein aggregation [1]. We found that inhibition of the Rac1–
Nox axis abrogated both oxidation within the ER and increased
PDI expression, strongly supporting a role for Nox-dependent
ROS in UPS.
Disruption of cellular GSH status can trigger UPS and apoptosis
(for review see [41]). In addition, Shamoto-Nagai et al have shown
that prolonged exposure (>48 h) of SHSY-5Y cells to rotenone leads
to apoptosis due to inactivation of the proteasome as a result of
oxidative/nitrosative modiﬁcations [33]. We found that rotenone
shifted the GSH redox status to a more oxidized state, impaired
UPS and induced apoptosis. Oxidative inactivation of the protea-
some would be consistent with our ﬁndings. Intriguingly, we found
that inhibition of Rac1 did not prevent mitochondrial ROS genera-
tion but it did prevent the shift in GSH redox balance, signiﬁcantly
decrease ER-stress, mitigate accumulation of ubiquitinated pro-
teins, and prevent the impaired UPS-mediated apoptotic cell death.
Together these results suggest that Rac1 plays a major role in im-
paired UPS by facilitating the formation and activation of the
NADPH oxidase complex. Future studies investigating whether
Nox-dependent ROS can lead to inactivation of the proteasome
are warranted.
In summary, using a cell model of neurodegenerative disease
we demonstrate that Rac1 is an important regulatory factor
which promotes activation of Nox. Activation of Nox induces
excessive ROS generation, which inﬂuences signaling cascades
such as calcium and prolonged UPR, resulting in impaired
UPS (see Fig. 6). Inhibition of Rac1 can rescue UPS function and
prevent apoptotic cell death. Our ﬁndings suggest that Rac1 could
be a potential therapeutic target for common neurodegenerative
diseases.
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